Apimeds Pharmaceuticals US
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell APUS and other ETFs, options, and stocks.About APUS
Apimeds Pharmaceuticals US, Inc. is a clinical stage biopharmaceutical company that engages in the development of Apitox, an intradermally administered bee venom-based toxin. It primarily focuses on developing innovative therapies for inflammation and pain management in knee osteoarthritis (OA) and, to a lesser extent, multiple sclerosis (MS).
APUS Key Statistics
Stock Snapshot
As of today, Apimeds Pharmaceuticals US(APUS) shares are valued at $1.37. The company's market cap stands at 17.23M, with a P/E ratio of -3.09.
On 2026-03-05, Apimeds Pharmaceuticals US(APUS) stock moved within a range of $1.29 to $1.37. With shares now at $1.37, the stock is trading +6.2% above its intraday low and 0.0% below the session's peak.
Trading volume for Apimeds Pharmaceuticals US(APUS) stock has reached 18.04K, versus its average volume of 249.73K.
Over the past 52 weeks, Apimeds Pharmaceuticals US(APUS) stock has traded between a high of $4.03 and a low of $0.95.
Over the past 52 weeks, Apimeds Pharmaceuticals US(APUS) stock has traded between a high of $4.03 and a low of $0.95.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.